High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening

SOURCE: Annals of Internal Medicine
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2006
TITLE AUTHOR(S): T.A.Peterman, L.H.Tian, C.A.Metcalf, C.L.Satterwhite, C.K.Malotte, N.DeAugustine, S.M.Paul, H.Cross, C.A.Rietmeijer, J.M.Douglas
KEYWORDS: SEXUALLY TRANSMITTED DISEASES
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 1709
HANDLE: 20.500.11910/7506
URI: http://hdl.handle.net/20.500.11910/7506

If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.

Abstract

Studies show 11% to 15% of women treated for Chlamydia trachomatis are reinfected 3 to 4 months after treatment, suggesting the need for rescreening. There is little information on infections among men, infections with Neisseria gonorrhoeae or Trichomonas vaginalis, or long-term follow-up. Objective: To determine the incidence of new sexually transmitted infections during the year after a visit to a sexually transmitted disease (STD) clinic and associated risk factors. Men and women who receive diagnoses of C. trachomatis, N. gonorrhoeae, or T. vaginalis infections should return in 3 months for rescreening because they are at high risk for new asymptomatic sexually transmitted infections. Although single-dose therapy may adequately treat the infection, it often does not adequately treat the patient.